TXG
#1295
10x Genomics, Inc. - Common Stock
41.7 7 USD
-0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.25%
Monthly Change
+40.50%
6 month change
+99.09%
Year Change
+202.24%
Previous Close
42.7 3
Open
41.7 7
Low
41.7 7
High
41.7 7
Volume
170
Financials
- Market Capitalization 5.3 B
- Employee 1 178
- Founded 2012
- CEO Serge Saxonov
- Website www.10xgenomics.com
- Headquarter Delaware, United States
- FIGI BBG007WX14X0
- Industry Health Information Services
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-124.88
Price to sales ratio
4.18
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 914 |  TEM Tempus AI, Inc. - Class A Common Stock | 55.93 USD | -3.95% | -7.55% | +11.90% | -5.11% | 10.04 B USD | ||
| 1031 |  HQY HealthEquity, Inc. - Common Stock | 95.66 USD | +1.33% | -2.16% | +7.76% | -1.00% | 8.00 B USD | ||
| 1484 |  DOCS Doximity, Inc. Class A Common Stock | 22.29 USD | +2.39% | -4.78% | +10.18% | -63.87% | 4.08 B USD | ||
| 1589 |  PRVA Privia Health Group, Inc. - Common Stock | 27.89 USD | +1.46% | +1.49% | +19.44% | +7.52% | 3.51 B USD |
Frequently asked questions about 10x Genomics, Inc. - Common Stock
What is the 10x Genomics, Inc. - Common Stock stock price today?
The current price of 10x Genomics, Inc. - Common Stock (TXG) is 41.77. Over the past 24 hours, the stock has changed by -2.25%. Follow the TXG chart for real-time price dynamics.
What is the stock ticker of 10x Genomics, Inc. - Common Stock?
10x Genomics, Inc. - Common Stock trades under the ticker TXG. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is 10x Genomics, Inc. - Common Stock stock going up?
TXG has changed by +4.90% over the last week, +40.50% over the last month, and +202.24% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was 10x Genomics, Inc. - Common Stock net income for the last quarter?
10x Genomics, Inc. - Common Stock reported net income of -13.47 M for the last quarter. The previous quarter showed -16.25 M, which means net income changed by +17.12%.
How many employees does 10x Genomics, Inc. - Common Stock have?
As of the latest available data, 10x Genomics, Inc. - Common Stock has 1 178 employees. Workforce size can provide additional context about the company's scale and operations.
What is 10x Genomics, Inc. - Common Stock EBITDA?
10x Genomics, Inc. - Common Stock EBITDA is -7.09 M, and its EBITDA margin is -4.7%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy 10x Genomics, Inc. - Common Stock stock?
You can buy 10x Genomics, Inc. - Common Stock (TXG) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in 10x Genomics, Inc. - Common Stock stock?
Investing in 10x Genomics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the TXG chart and related analysis on metatrader.com as part of your research.